Effect of sucralfate on gastric intramucosal pH in critically ill patients

Intensive Care Med. 1997 Jul;23(7):738-42. doi: 10.1007/s001340050402.

Abstract

Objective: To determine whether sucralfate administration affects the tonometric measurement of gastric intramucosal pH (pHi).

Design: Non-randomized observational study.

Setting: General intensive care unit of a teaching hospital.

Patients: Twenty critically ill, mechanically ventilated, consecutively admitted patients requiring an arterial catheter and nasogastric tube.

Interventions: Tonometer placement and sucralfate administration.

Measurements and main results: We simultaneously determined tonometer saline PCO2 (PCO2i), arterial blood gases, pH of gastric juice and pHi. These parameters were evaluated immediately before sucralfate administration, and 2 h and 4 h after. We did not detect any change in either PCO2i or pHi after sucralfate administration (PCO2i: basal 6.4 +/- 1.7, 2 h 6.3 +/- 1.7, 4 h 6.3 +/- 1.7; pHi: basal 7.35 +/- 0.13, 2 h 7.36 +/- 0.12, 4 h 7.36 +/- 0.12).

Conclusions: Sucralfate does not affect the tonometric measurement of PCO2i and pHi.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Analysis of Variance
  • Anti-Ulcer Agents* / therapeutic use
  • Blood Gas Analysis
  • Critical Illness / therapy*
  • Drug Monitoring
  • Female
  • Gastric Acidity Determination
  • Gastric Mucosa / drug effects*
  • Humans
  • Hydrogen-Ion Concentration
  • Male
  • Middle Aged
  • Respiration, Artificial
  • Sucralfate / therapeutic use*
  • Time Factors

Substances

  • Anti-Ulcer Agents
  • Sucralfate